Answers are grounded in this paper and cite their sources.
// Chia-Ming Yeh 1, * , Shih-Chi Su 2, * , Chiao-Wen Lin 3, 4 , Wei-En Yang 1, 5 , Ming-Hsien Chien 6 , Russel J. Reiter 7 and Shun-Fa Yang 1, 5 1 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan 2 Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan 3 Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan 4 Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan 5 Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan 6 Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan 7 Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA * These authors contributed equally to the work Correspondence to: Russel J. Reiter, email: reiter@uthscsa.edu Shun-Fa Yang, email: ysf@csmu.edu.tw Keywords: melatonin, head and neck cancers, metastasis, matrix metalloproteinase Received: June 06, 2017 Accepted: July 26, 2017 Published: August 09, 2017 ABSTRACT Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.
No takes yet. Share an insight, caveat, or question.
Yeh et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: